Pharmafile Logo
Pharmafocus logo
Advanced Search

AAX Biotech and Daiichi Sankyo partner to evaluate antibody therapeutics

October 31, 2025
AAX Biotech, Daiichi Sankyo, Opti-mAb, Seqitope

AAX Biotech, a Swedish biotechnology company specialising in next-generation antibody therapeutics, has launched a strategic partnership with Daiichi Sankyo, a …

News
partnership

Landmark Bio and Mass General Brigham partner to accelerate translational CGT therapies

October 30, 2025
Research and Development Landmark Bio, Mass General Brigham, cell and gene therapies, partnership

Landmark Bio and Mass General Brigham in the US have entered a new strategic collaboration designed to accelerate the development …

News

Is this an Oppenheimer moment for the life sciences industry?

October 29, 2025
Business Services, Market Access, Market Access Consultancy, Sales and Marketing NHS, Visions4Health

By Sabina Syed, Managing Director at Visions4Health In the history of science, few initiatives demonstrate the magnitude of coordinated effort …

Feature
Thought Leadership
drug-trials

Pharma&’s ovarian cancer therapy approved for use by NHS Scotland

October 29, 2025
Pharma&, Rubraca, Scottish Medicines Consortium, nhs scotland, oncology, ovarian cancer

Pharma& has announced that its treatment for ovarian cancer, Rubraca (rucaparib), has been accepted by the Scottish Medicines Consortium (SMC) …

News

BioMedX launches R&D accelerator to advance women’s health

October 28, 2025
Research and Development BioMedX, Gates Foundation, Women’s Health

BioMed X, an independent research institute with sites in Germany and the United States, has announced the launch of XFem …

News

Berlin Heals appoints Dr Eric Fain as new board member

October 28, 2025
Berlin Heals, Cardiovascular Health, chronic heart failure, medtech

Berlin Heals, a clinical-stage medical device company focused on treating chronic heart failure, has appointed Dr Eric S Fain to …

Appointment

Turning a 10-Year Vision into a 10-Year Plan

October 27, 2025
Business Services, Market Access, Market Access Consultancy Corporate, Gateway to Local Adoption, NHS, Pharmacy, Population Health Management, Visions4Health, pharmacy

In the sixth of the Gateway to Local Adoption series, Visions4Health’s Head of Client Services, Jonny Savage, shares his views …

Feature

Sharp invests $100m in US and EU manufacturing and packaging facilities

October 27, 2025
Manufacturing and Production EU, Sharp Services, US, manufacturing and packaging

Sharp Services, a pharmaceutical packaging and sterile manufacturing specialist, has announced investments totalling $100m across its US and European facility …

News
partnership

NNIT partners with global biopharma company for regulatory registration management

October 24, 2025
Business Services IT, NNIT, digital solutions, regulatory

NNIT, a Danish provider of digital software and IT services, has entered a long-term strategic partnership with a global biopharmaceutical …

News
drug-trials

THX Pharma and Exeltis announce first milestone achieved for neurological disease treatment

October 23, 2025
Research and Development Neurological Diseases, THX Pharma, Theranexus

THX Pharma (Theranexus), a pharma company focusing on developing treatments for rare neurological disease, and Exeltis, a pharma company within …

News

Excellence in Healthcare Partnerships (EHP) Awards Networking Event

October 23, 2025
Medical Communications EHP Awards

From plan to partnership: navigating the enablers and challenges of collaborative working. How has the 10-year healthcare plan and Life …

News
handshake-2056023_960_720

PolyNovo welcomes Bruce Peatey as CEO

October 22, 2025
CEO, Market Expansion, PolyNovo, medtech, wound care

PolyNovo, an Australian medtech company specialising in acute complex wound management, has appointed Bruce Peatey as its new chief executive …

Appointment

Recipharm offers manufacturing support to vaccine trial from ImmBIO and iiCON

October 21, 2025
Manufacturing and Production ImmunBiology, Infection Innovation Consortium, Recipharm, Vaccine, pneumococcal disease

Recipharm, a contract development and manufacturing organisation (CDMO), has successfully manufactured PnuBioVax, a new protein-based vaccine against pneumococcal disease, developed …

News

IMed Consultancy releases white paper on Digital Mental Health Technologies

October 20, 2025
Medical Communications Digital Mental Health Technologies, IMed Consultancy, MHRA

IMed Consultancy, a consultancy and service provider for the medical and health technology sector, has published a new white paper …

News

Chemify relocates to Glasgow’s new Health Innovation Hub

October 17, 2025
Research and Development Chemify, Kadans Science Partner, Scotland

The company will be one of the first tenants in the city’s flagship life sciences facility

News

Oxford North UK innovation district officially opened

October 16, 2025
Research and Development Oxford North, University of Oxford, innovation district

Oxford North, a new innovation district in Oxford, UK, with planning permission for around one million sq ft of newly …

News

Julius Clinical appoints Bassem Saleh as CEO

October 16, 2025
Julius Clinical, cardiometabolic diseases, central nervous system

Julius Clinical, a Netherlands-based clinical research organisation (CRO), has appointed Bassem Saleh as its new chief executive officer (CEO). Saleh …

Appointment
brain_anatomy_medical_head_skull_digital_3_d_x_ray_xray_psychedelic_3720x2631_1

Alto Neuroscience’s schizophrenia treatment granted FDA Fast Track designation

October 14, 2025
Alto Neuroscience, FDA, schizophrenia

Alto Neuroscience has announced that its investigational treatment for cognitive impairment associated with schizophrenia (CIAS) has received Fast Track designation …

News

FairJourney Biologics appoints Dr Werner Lanthaler as CEO

October 14, 2025
FairJourney Biologics

FairJourney Biologics (FJBio), Portuguese antibody discovery and development company, has appointed Dr Werner Lanthaler as its new chief executive officer. …

Appointment
drug-trials

ANGLE unveils new strategy with executive reshuffle and name change to CelLBx Health

October 13, 2025
Business Services Angle

ANGLE has outlined a revised business strategy centred on tighter cost management, accelerated commercial execution, and long-term sustainability. The update …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025